IND submitted for opaganib, potential COVID-19 treatment
RedHill Biopharma has submitted its Investigational New Drug application for…
RedHill Biopharma has submitted its Investigational New Drug application for its drug opaganib, for the treatment of COVID-19, to the FDA.